HUND; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUND; Martin.The latest application filed is for "s100a9 as blood biomarker for the non-invasive diagnosis of endometriosis".

Company Profile

5.5.17

HUND; Martin - Horw CH
Hund; Martin - Rotkreuz CH
Hund; Martin - Rettert DE
Hund; Martin - Allensbach DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
S100a9 As Blood Biomarker For The Non-invasive Diagnosis Of Endometriosis App 20220155315 - GEORGOPOULOU; Aikaterini ; et al.	2022-05-19
S100a6 As Blood Biomarker For The Non-invasive Diagnosis Of Endometriosis App 20220137058 - GEORGOPOULOU; Aikaterini ; et al.	2022-05-05
S100a8 As Blood Biomarker For The Non-invasive Diagnosis Of Endometriosis App 20220137068 - GEORGOPOULOU; Aikaterini ; et al.	2022-05-05
Substance P As Blood Biomarker For The Non-invasive Diagnosis Of Endometriosis App 20220137052 - ANDERS; Carolin ; et al.	2022-05-05
S100a12 As Blood Biomarker For The Non-invasive Diagnosis Of Endometriosis App 20220137069 - GEORGOPOULOU; Aikaterini ; et al.	2022-05-05
DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME App 20220128568 - Denk; Barbara ; et al.	2022-04-28
Prediction Of Preeclampsia Based On Igfbp-7 App 20210140971 - Hund; Martin ; et al.	2021-05-13
Prediction Of Postpartum Hellp Syndrome, Postpartum Eclampsia Or Postpartum Preeclampsia App 20200378981 - Hund; Martin ; et al.	2020-12-03
Method for setting up a local control channel between a control unit and a building-internal access portal Grant 10,425,245 - Hund , et al. Sept	2019-09-24
DYNAMIC OF SFLT-1 OR ENDOGLiN/PIGF RATIO AS AN INDICATOR FOR IMMINENT PREECLAMPSIA AND/OR HELLP SYNDROME App 20190227074 - Denk; Barbara ; et al.	2019-07-25
Controlling communication between a building-external communication server and a building-internal communication entity Grant 10,356,236 - Hund , et al. July 16, 2	2019-07-16
Dynamic of sFlt-1 or endoglin/PLGF ratio as an indicator for imminent preeclampsia and/or HELLP syndrome Grant 10,302,657 - Denk , et al.	2019-05-28
Igfbp-7 As A Marker Of Preeclampsia App 20180364248 - Hund; Martin ; et al.	2018-12-20
Migration of control elements in a building control system Grant 10,091,016 - Hund , et al. October 2, 2	2018-10-02
Prediction Of Postpartum Hellp Syndrome, Postpartum Eclampsia Or Postpartum Preeclampsia App 20160327564 - Hund; Martin ; et al.	2016-11-10
Migration Of Control Elements In A Building Control System App 20160154393 - Hund; Martin ; et al.	2016-06-02
Method For Setting Up A Local Control Channel Between A Control Unit And A Building-internal Access Portal App 20160134432 - Hund; Martin ; et al.	2016-05-12
Controlling Communication Between A Building-external Communication Server And A Building-internal Communication Entity App 20160094701 - Hund; Martin ; et al.	2016-03-31
MEANS AMD METHODS APPLYING sFlt-1/PIGF OR ENDOGLIN/PIGF RATIO TO RULE OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD App 20150338415 - Hund; Martin ; et al.	2015-11-26
Dynamic Of Sflt-1 Or Endoglin/plgf Ratio As An Indicator For Imminent Preeclampsia And/or Hellp Syndrome App 20140234879 - Denk; Barbara ; et al.	2014-08-21
Method and device for processing color information of a pattern having cluttered and useful information characters Grant 7,583,836 - Hund September 1, 2	2009-09-01
Method and device for processing colour information of a pattern having cluttered and useful information characters App 20060210149 - Hund; Martin	2006-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.